Anika Therapeutics, Inc. (NASDAQ: ANIK) Stock Competitors & Peer Comparison
See ANIK's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ANIK and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ANIK | $20.99 | +0.53% | 280.9M | 42.84 | $0.49 | N/A |
| ALC | $66.55 | -2.75% | 32.5B | 20.93 | $3.18 | +0.52% |
| STE | $212.45 | -1.23% | 20.7B | 20.39 | $10.42 | +1.20% |
| QDEL | $12.15 | -3.88% | 828.5M | 9.07 | $1.34 | N/A |
| MLAB | $120.91 | -2.42% | 676.6M | 12.20 | $9.91 | +0.51% |
| BWAY | $13.91 | -3.47% | 545.6M | 35.34 | $0.39 | N/A |
| SI | $19.11 | -2.70% | 396.1M | -11.04 | -$1.73 | N/A |
| MASS | $9.35 | -3.51% | 383.6M | -15.58 | -$0.60 | N/A |
| MOBI | $10.25 | -5.27% | 340.8M | -0.55 | -$18.78 | N/A |
| LAB | $0.69 | -0.33% | 284.6M | -10.39 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
ANIK vs ALC Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, ALC has a market cap of 32.5B. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while ALC trades at $66.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas ALC's P/E ratio is 20.93. In terms of profitability, ANIK's ROE is -0.03%, compared to ALC's ROE of +0.03%. Regarding short-term risk, ANIK is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for ANIK.Check ALC's competition here
STERIS plc (NYSE: STE)
ANIK vs STE Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, STE has a market cap of 20.7B. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while STE trades at $212.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas STE's P/E ratio is 20.39. In terms of profitability, ANIK's ROE is -0.03%, compared to STE's ROE of +0.11%. Regarding short-term risk, ANIK is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for ANIK.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
ANIK vs QDEL Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, QDEL has a market cap of 828.5M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while QDEL trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas QDEL's P/E ratio is 9.07. In terms of profitability, ANIK's ROE is -0.03%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, ANIK is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
ANIK vs MLAB Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, MLAB has a market cap of 676.6M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while MLAB trades at $120.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas MLAB's P/E ratio is 12.20. In terms of profitability, ANIK's ROE is -0.03%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, ANIK is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
ANIK vs BWAY Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, BWAY has a market cap of 545.6M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while BWAY trades at $13.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas BWAY's P/E ratio is 35.34. In terms of profitability, ANIK's ROE is -0.03%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, ANIK is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check BWAY's competition here
Shoulder Innovations, Inc. (NYSE: SI)
ANIK vs SI Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, SI has a market cap of 396.1M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while SI trades at $19.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas SI's P/E ratio is -11.04. In terms of profitability, ANIK's ROE is -0.03%, compared to SI's ROE of -0.26%. Regarding short-term risk, ANIK is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check SI's competition here
908 Devices Inc. (NASDAQ: MASS)
ANIK vs MASS Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, MASS has a market cap of 383.6M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while MASS trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas MASS's P/E ratio is -15.58. In terms of profitability, ANIK's ROE is -0.03%, compared to MASS's ROE of -0.25%. Regarding short-term risk, ANIK is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
ANIK vs MOBI Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, MOBI has a market cap of 340.8M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while MOBI trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas MOBI's P/E ratio is -0.55. In terms of profitability, ANIK's ROE is -0.03%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, ANIK is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
ANIK vs LAB Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, LAB has a market cap of 284.6M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while LAB trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas LAB's P/E ratio is -10.39. In terms of profitability, ANIK's ROE is -0.03%, compared to LAB's ROE of -0.18%. Regarding short-term risk, ANIK is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check LAB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
ANIK vs EDAP Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas EDAP's P/E ratio is -5.80. In terms of profitability, ANIK's ROE is -0.03%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, ANIK is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check EDAP's competition here
Trinity Biotech plc (NASDAQ: TRIB)
ANIK vs TRIB Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, TRIB has a market cap of 157.8M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while TRIB trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas TRIB's P/E ratio is -0.13. In terms of profitability, ANIK's ROE is -0.03%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, ANIK is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check TRIB's competition here
Nyxoah S.A. (NASDAQ: NYXH)
ANIK vs NYXH Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, NYXH has a market cap of 150.1M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while NYXH trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas NYXH's P/E ratio is -0.60. In terms of profitability, ANIK's ROE is -0.03%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, ANIK is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
ANIK vs APYX Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, APYX has a market cap of 121.7M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while APYX trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas APYX's P/E ratio is -14.45. In terms of profitability, ANIK's ROE is -0.03%, compared to APYX's ROE of -0.79%. Regarding short-term risk, ANIK is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
ANIK vs SKIN Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, SKIN has a market cap of 89.4M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while SKIN trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas SKIN's P/E ratio is -3.14. In terms of profitability, ANIK's ROE is -0.03%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, ANIK is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
ANIK vs MDAI Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, MDAI has a market cap of 49.6M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while MDAI trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas MDAI's P/E ratio is -3.47. In terms of profitability, ANIK's ROE is -0.03%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, ANIK is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
ANIK vs DRIO Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, DRIO has a market cap of 48.7M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while DRIO trades at $6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas DRIO's P/E ratio is -1.14. In terms of profitability, ANIK's ROE is -0.03%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, ANIK is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
ANIK vs BEAT Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, BEAT has a market cap of 22.8M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while BEAT trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas BEAT's P/E ratio is -0.80. In terms of profitability, ANIK's ROE is -0.03%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, ANIK is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
ANIK vs BEATW Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, BEATW has a market cap of 8.6M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas BEATW's P/E ratio is -0.02. In terms of profitability, ANIK's ROE is -0.03%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, ANIK is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
ANIK vs WOK Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, WOK has a market cap of 4.8M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while WOK trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas WOK's P/E ratio is N/A. In terms of profitability, ANIK's ROE is -0.03%, compared to WOK's ROE of -0.19%. Regarding short-term risk, ANIK is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
ANIK vs QTEXW Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, ANIK's ROE is -0.03%, compared to QTEXW's ROE of N/A. Regarding short-term risk, ANIK is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
ANIK vs ITOC Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, ITOC has a market cap of 2.9M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while ITOC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas ITOC's P/E ratio is -0.98. In terms of profitability, ANIK's ROE is -0.03%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, ANIK is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
ANIK vs FEED Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, FEED has a market cap of 2.8M. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while FEED trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas FEED's P/E ratio is -0.03. In terms of profitability, ANIK's ROE is -0.03%, compared to FEED's ROE of -0.60%. Regarding short-term risk, ANIK is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
ANIK vs TIVC Comparison September 2026
Anika Therapeutics, Inc. (NASDAQ: ANIK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANIK stands at 280.9M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, ANIK is priced at $20.99 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANIK currently has a P/E ratio of 42.84, whereas TIVC's P/E ratio is -0.04. In terms of profitability, ANIK's ROE is -0.03%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, ANIK is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for ANIK.Check TIVC's competition here